Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1988-01-15
1990-03-06
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A61K 3123
Patent
active
049066641
ABSTRACT:
A method of treating cancer cachexia syndrome has been discovered. Total parenteral nutrition using structured lipids in place of long chain fatty acids as the primary lipid source provides improvements in nitrogens balance, plasma serum albumin levels, and glucose clearance rate.
REFERENCES:
patent: 4528197 (1985-07-01), Blackburn
patent: 4607052 (1986-08-01), Mendy et al.
patent: 4703062 (1987-10-01), Blackburn et al.
Mok et al., (1984) Metabolism; 33: 910-915.
Handbook of Physics and Chemistry 57th ed. CRC Press pp. D216-217, Robert Weast editor.
"Medium-chain triglycerides: an update," Back and Babayan, Amer. J. of Clin. Nut., 38: Nov. 1982, pp. 950-962.
"Improved Protein Kinetics and Albumin Synthesis by Branched Chain Amino Acid-Enriched total Parenteral Nutrition in Caner Cachexia," Tayek et al., Cancer, 58: No. 1, Jul. 1, 1986.
"Some Practical and Theoretic Concepts in the Nutritional Assessment of the Cancer Patient," Bistrian, Cancer, 58: No. 8, Oct. 15, 1986.
Babayan Vigen R.
Bistrian Bruce R.
Blackburn George L.
Goldberg Jerome D.
Henley, VIII
New England Deaconess Hospital Corporation
LandOfFree
Nutritional supplement for treatment of cancer cachexia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nutritional supplement for treatment of cancer cachexia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nutritional supplement for treatment of cancer cachexia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-47825